🇺🇸 Polyunsaturated fatty acids omega-3 in United States

9 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 9

Most-reported reactions

1. Arthralgia — 1 report (11.11%)
2. Butterfly Rash — 1 report (11.11%)
3. Fatigue — 1 report (11.11%)
4. Glomerulonephritis Membranous — 1 report (11.11%)
5. Lupus-Like Syndrome — 1 report (11.11%)
6. Mitral Valve Incompetence — 1 report (11.11%)
7. Nephrotic Syndrome — 1 report (11.11%)
8. Oedema Peripheral — 1 report (11.11%)
9. Skin Lesion — 1 report (11.11%)

Source database →

Frequently asked questions

Is Polyunsaturated fatty acids omega-3 approved in United States?

Polyunsaturated fatty acids omega-3 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Polyunsaturated fatty acids omega-3 in United States?

Hospital San Juan de la Cruz is the originator. The local marketing authorisation holder may differ — check the official source linked above.